Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial

Lara Caldiroli, Simone Vettoretti, Silvia Armelloni, Deborah Mattinzoli, Masami Ikehata, Paolo Molinari, Carlo Alfieri, Piergiorgio Messa, Giuseppe Castellano, Lara Caldiroli, Simone Vettoretti, Silvia Armelloni, Deborah Mattinzoli, Masami Ikehata, Paolo Molinari, Carlo Alfieri, Piergiorgio Messa, Giuseppe Castellano

Abstract

Background: Current guidelines do not clarify whether older patients with advanced chronic kidney disease (CKD) may benefit of low protein (LP) diet if they are at risk of malnutrition. We compared the effects of normocalorie/normoprotein (NP) and normocalorie/LP diet on nutritional status and metabolic complications related to the progression of kidney damage in these patients.

Methods: This pilot study had an open-label randomized-controlled design (ClinicalTrials.gov Id: NCT05015647). Thirty-five patients were treated for 6 months with two different diets (LP = 17) and (NP = 18). Malnutrition was assessed by the Malnutrition Inflammation Score and International Society of Renal Nutrition and Metabolism criteria. Renal function was assessed by creatinine and cystatin-C-based estimated glomerular filtration rate (eGFR).

Results: At the end of the study, Malnutrition Inflammation Score was improved in both LP and NP groups (respectively: 3 ± 3 vs. 6 ± 1.5, p = 0.020 and 3 ± 2.5 vs. 6 ± 2, p = 0.012), prevalence of protein energy wasting syndrome decreased only in LP. LP group had higher eGFRcys-C (17 ± 6 vs. 12 ± 4 ml/min/1.73 m2; p < 0.05), lower serum urea (105 ± 65 vs. 138 ± 30 mg/dl; p < 0.05) and lower parathormone (68 ± 10 vs. 99 ± 61 ng/L; p < 0.05) than NP. Serum and urinary phosphorous did not change while fibroblast growth factor 23 (FGF23)-intact and FGF23 c-terminal increased in both groups [FGF23-intact in LP: 70 (48; 98) vs. 126 (90; 410) pg/ml, p < 0.01 and in NP: 86 (57; 194) vs. 143 (119; 186) pg/ml, p < 0.01; FGF23 c-terminal in LP: 77 (30.3; 112) vs. 111 (63; 384) RU/ml, p < 0.01 and in NP: 142 (56.6; 175) vs. 157 (76.7; 281) RU/ml, p < 0.01].

Conclusions: LP diet has a favorable impact on nutritional status as much as NP diet with possible greater benefits on the progression of kidney disease and some of its metabolic complications.

Clinical trial registration: https://ichgcp.net/clinical-trials-registry/NCT05015647, identifier: NCT05015647.

Keywords: FGF23; chronic kidney disease; inflammation; low protein diet; malnutrition.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Caldiroli, Vettoretti, Armelloni, Mattinzoli, Ikehata, Molinari, Alfieri, Messa and Castellano.

References

    1. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. (1995) 6:1386–91. 10.1681/ASN.V651386
    1. Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. . Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant. (2015) 30:1718–25. 10.1093/ndt/gfv133
    1. Cuppari L, Meireles MS, Ramos CI, Kamimura MA. Subjective global assessment for the diagnosis of protein-energy wasting in nondialysis-dependent chronic kidney disease patients. J Ren Nutr. (2014) 24:385–9. 10.1053/j.jrn.2014.05.004
    1. Mitch WE. Cachexia in chronic kidney disease: a link to defective central nervous system control of appetite. J Clin Invest. (2005) 115:1476–8. 10.1172/JCI25255
    1. Cupisti A, Brunori G, Di Iorio BR, D'Alessandro C, Pasticci F, Cosola C, et al. . Nutritional treatment of advanced CKD: twenty consensus statements. J Nephrol. (2018) 31:457–73. 10.1007/s40620-018-0497-z
    1. Rhee CM, Ahmadi SF, Kovesdy CP, Kalantar-Zadeh K. Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials. J Cachexia Sarcopenia Muscle. (2018) 9:235–45. 10.1002/jcsm.12264
    1. Fois A, Chatrenet A, Cataldo E, Lippi F, Kaniassi A, Froger L, et al. . Moderate protein restriction in advanced CKD: a feasible option in an elderly, high-comorbidity population. a stepwise multiple-choice system approach. Nutrients. (2019) 11:36. 10.3390/nu11010036
    1. Tom K, Young VR, Chapman T, Masud T, Akpele L, Maroni BJ. Long-term adaptive responses to dietary protein restriction in chronic renal failure. Am J Physiol Endocrinol Metab. (1995) 268:E668–77. 10.1152/ajpendo.1995.268.4.E668
    1. Masud T, Young VR, Chapman T, Maroni BJ. Adaptive response to very low protein diets: the first comparison of Ketoacids to essential amino acids. Kidney Int. (1994) 45:1182–92. 10.1038/ki.1994.157
    1. Goodship TH, Mitch WE, Hoerr RA, Wagner DA, Steinman TI, Young VR. Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. J Am Soc Nephrol. (1990) 1:66–75. 10.1681/ASN.V1166
    1. Kopple JD, Monteon FJ, Shaib JK. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int. (1986) 29:734–42. 10.1038/ki.1986.59
    1. Garibotto G, Sofia A, Parodi EL, Ansaldo F, Bonanni A, Picciotto D, et al. . Effects of low-protein, and supplemented very low–protein diets, on muscle protein turnover in patients with CKD. Kidney Int Rep. (2018) 3:701–10. 10.1016/j.ekir.2018.01.003
    1. Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. . KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. (2020) 76:S1–107. 10.1053/j.ajkd.2020.05.006
    1. Zoccali C, Mallamaci F. Moderator's view: low-protein diet in chronic kidney disease: effectiveness, efficacy and precision nutritional treatments in nephrology. Nephrol Dial Transplant. (2018) 33:387–91. 10.1093/ndt/gfx374
    1. Hanna RM, Ghobry L, Wassef O, Rhee CM, Kalantar-Zadeh K. A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif . (2020) 49:202–11. 10.1159/000504240
    1. Farrington K, Covic A, Aucella F, Clyne N, de Vos L, Findlay A, et al. . Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR &lt;45 mL/min/1.73 m 2). Nephrol Dial Transplant. (2016) 31(Suppl. 2):ii1–66. 10.1093/ndt/gfw356
    1. Deer RR, Volpi E. Protein requirements in critically ill older adults. Nutrients. (2018) 10:378. 10.3390/nu10030378
    1. Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: a confidence interval approach. J Clin Epidemiol. (2013) 66:197–201. 10.1016/j.jclinepi.2012.09.002
    1. Suresh K. An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J Hum Reprod Sci. (2011) 4:8–11. 10.4103/0974-1208.82352
    1. Vettoretti S, Caldiroli L, Armelloni S, Ferrari C, Cesari M, Messa P. Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD. Nutrients. (2019) 11:1378. 10.3390/nu11061378
    1. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A Malnutrition-Inflammation Score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. (2001) 38:1251–63. 10.1053/ajkd.2001.29222
    1. Afşar B, Sezer S, Ozdemir FN, Celik H, Elsurer R, Haberal M. Malnutrition-inflammation score is a useful tool in peritoneal dialysis patients. Perit Dial Int. (2006) 26:705–11. 10.1177/089686080602600616
    1. Fouque D, Kalantar-Zadeh K, Kopple J, Chauveau P, Cuppari L, Franch H, et al. . A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int. (2008) 73:391–8. 10.1038/sj.ki.5002585
    1. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. (1985) 27:58–65. 10.1038/ki.1985.10
    1. Legrand D, Vaes B, Matheï C, Adriaensen W, Van Pottelbergh G, Degryse JM. Muscle strength and physical performance as predictors of mortality, hospitalization, and disability in the oldest old. J Am Geriatr Soc. (2014) 62:1030–8. 10.1111/jgs.12840
    1. Treacy D, Hassett L. The short physical performance battery. J Physiother. (2018) 64:61. 10.1016/j.jphys.2017.04.002
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. (2019) 48:16–31. 10.1093/ageing/afz046
    1. Mele A, D'Angelo F, De Masi S. Linee Guida Nazionali: Identificazione, prevenzione e gestione della malattia renale cronica nell'adulto. ISS (2012). Available online at:
    1. Linee Guida per la terapia conservativa dell'insufficienza renale cronica . Giornale Italiano Nefrol. (2003) S-24:S48–60.
    1. NICE: Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. London: (2010).
    1. Torreggiani M, Chatrenet A, Fois A, Moio MR, Mazé B, Coindre JP, et al. . Elderly patients in a large nephrology unit: who are our old, old-old and oldest-old patients? J Clin Med. (2021) 10:1168. 10.3390/jcm10061168
    1. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. . Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. (2012) 367:20–9. 10.1056/NEJMoa1114248
    1. Björk J, Grubb A, Gudnason V, Indridason OS, Levey AS, Palsson R, et al. . Comparison of glomerular filtration rate estimating equations derived from creatinine and cystatin C: validation in the Age, Gene/Environment Susceptibility-Reykjavik elderly cohort. Nephrol Dial Transplant. (2018) 33:1380–8. 10.1093/ndt/gfx272
    1. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. . Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. (2009) 75:652–60. 10.1038/ki.2008.638
    1. Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, Greene T, et al. . Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int. (2011) 79:471–7. 10.1038/ki.2010.431
    1. Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. (2018) 13:952–61. 10.2215/CJN.10390917
    1. Darmon P, Kaiser MJ, Bauer JM, Sieber CC, Pichard C. Restrictive diets in the elderly: never say never again? Clin Nutr. (2010) 29:170–4. 10.1016/j.clnu.2009.11.002
    1. Wolfe RR, Miller SL, Miller KB. Optimal protein intake in the elderly. Clin Nutr. (2008) 27:675–84. 10.1016/j.clnu.2008.06.008
    1. Nutrients and Energy Reference Intake for Italian Population . 4th Rev. Milan: SINU (Italian Society of Human Nutrition) (2014).
    1. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. (2020) 98:S1–115. 10.1016/j.kint.2020.06.019
    1. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. . Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the prot-age study group. J Am Med Dir Assoc. (2013) 14:542–59. 10.1016/j.jamda.2013.05.021

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe